@article{taylor_inclusion_2004,
	title = {Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle},
	volume = {329},
	issn = {0959-8138},
	shorttitle = {Inclusion of cost effectiveness in licensing requirements of new drugs},
	url = {http://www.ncbi.nlm.nih.gov/pmc/articles/PMC524116/},
	abstract = {Increasing numbers of countries are considering cost effectiveness in decisions about which drugs to make available for prescription. How do the different approaches work and is it time for standardisation?},
	number = {7472},
	urldate = {2015-02-28},
	journal = {BMJ : British Medical Journal},
	author = {Taylor, R S and Drummond, M F and Salkeld, G and Sullivan, S D},
	month = oct,
	year = {2004},
	pmid = {15499118},
	pmcid = {PMC524116},
	pages = {972--975},
}

{"_id":"zwqRAcKbm6puJPLgj","bibbaseid":"taylor-drummond-salkeld-sullivan-inclusionofcosteffectivenessinlicensingrequirementsofnewdrugsthefourthhurdle-2004","author_short":["Taylor, R S","Drummond, M F","Salkeld, G","Sullivan, S D"],"bibdata":{"bibtype":"article","type":"article","title":"Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle","volume":"329","issn":"0959-8138","shorttitle":"Inclusion of cost effectiveness in licensing requirements of new drugs","url":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC524116/","abstract":"Increasing numbers of countries are considering cost effectiveness in decisions about which drugs to make available for prescription. How do the different approaches work and is it time for standardisation?","number":"7472","urldate":"2015-02-28","journal":"BMJ : British Medical Journal","author":[{"propositions":[],"lastnames":["Taylor"],"firstnames":["R","S"],"suffixes":[]},{"propositions":[],"lastnames":["Drummond"],"firstnames":["M","F"],"suffixes":[]},{"propositions":[],"lastnames":["Salkeld"],"firstnames":["G"],"suffixes":[]},{"propositions":[],"lastnames":["Sullivan"],"firstnames":["S","D"],"suffixes":[]}],"month":"October","year":"2004","pmid":"15499118","pmcid":"PMC524116","pages":"972–975","bibtex":"@article{taylor_inclusion_2004,\n\ttitle = {Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle},\n\tvolume = {329},\n\tissn = {0959-8138},\n\tshorttitle = {Inclusion of cost effectiveness in licensing requirements of new drugs},\n\turl = {http://www.ncbi.nlm.nih.gov/pmc/articles/PMC524116/},\n\tabstract = {Increasing numbers of countries are considering cost effectiveness in decisions about which drugs to make available for prescription. How do the different approaches work and is it time for standardisation?},\n\tnumber = {7472},\n\turldate = {2015-02-28},\n\tjournal = {BMJ : British Medical Journal},\n\tauthor = {Taylor, R S and Drummond, M F and Salkeld, G and Sullivan, S D},\n\tmonth = oct,\n\tyear = {2004},\n\tpmid = {15499118},\n\tpmcid = {PMC524116},\n\tpages = {972--975},\n}\n\n","author_short":["Taylor, R S","Drummond, M F","Salkeld, G","Sullivan, S D"],"key":"taylor_inclusion_2004","id":"taylor_inclusion_2004","bibbaseid":"taylor-drummond-salkeld-sullivan-inclusionofcosteffectivenessinlicensingrequirementsofnewdrugsthefourthhurdle-2004","role":"author","urls":{"Paper":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC524116/"},"metadata":{"authorlinks":{}},"html":""},"bibtype":"article","biburl":"https://bibbase.org/zotero/robin.marlow","dataSources":["ix72eqAAMGCuupBaz"],"keywords":[],"search_terms":["inclusion","cost","effectiveness","licensing","requirements","new","drugs","fourth","hurdle","taylor","drummond","salkeld","sullivan"],"title":"Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle","year":2004}